These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3674892

  • 1. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Furusawa T, Maegawa M, Kaiho H.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Results of combination chemotherapy in advanced urothelial cancer].
    Komatsubara S, Watanabe M, Kitamura Y, Sakata Y.
    Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy of advanced transitional cell carcinoma with cis-platinum, cyclophosphamide, adriamycin and 5-fluorouracil (CISCAF)].
    Fujioka H, Tada Y, Nakano E, Matsuda M, Osafune M, Sagawa S, Takaha M, Sonoda T.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1612-6. PubMed ID: 6541019
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
    Campbell M, Baker LH, Opipari M, Al-Sarraf M.
    Cancer Treat Rep; 1981 Aug; 65(9-10):897-9. PubMed ID: 7196800
    [Abstract] [Full Text] [Related]

  • 7. [Cyclophosphamide, adriamycin and cisplatinum combination chemotherapy for advanced urothelial and prostatic carcinoma].
    Tsukamoto T, Tanoguchi H, Nakazono M, Murai M, Tachibana M, Deguchi N, Baba S, Hata M, Jitsukawa S, Tazaki H.
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3259-64. PubMed ID: 3688891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Dec; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 10. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
    Nakanishi F, Sugiishi M, Ogasawara T, Sugiura I, Kinoshita T, Ito Y, Hoshino A.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A, Den S, Nakamura I, Ohshima H, Nagata H, Izumi T, Takechi Y, Kawaida T, Kamidono S, Yasuno H.
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [Abstract] [Full Text] [Related]

  • 13. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K, Sakuramoto T, Washizuka M, Kawai T, Ogawa M.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
    [Abstract] [Full Text] [Related]

  • 14. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
    Sánchez Romero JA, Ramírez Ruiz F, Romero Fernández L, Pastor Gaitán P, Murillo Capitán E.
    Actas Urol Esp; 1989 Nov; 13(4):240-2. PubMed ID: 2678934
    [Abstract] [Full Text] [Related]

  • 15. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for poor prognosis patients with urothelial tumors and effect of dose intensity.
    Hibi H, Okamura K, Takashi M, Shimoji T, Miyake K.
    Hinyokika Kiyo; 1997 Feb; 43(2):89-96. PubMed ID: 9086342
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine, and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
    Nakanishi F, Mogi H, Sugiishi M, Sugiura I, Ogasawara T, Kinoshita T, Hoshino A.
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3413-8. PubMed ID: 3466573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.